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eCAM continues as it began in its quest for providing
linkages and revealing the interdependence of basic
science and clinical analyses. If one examines the 50
most cited papers for the month of June 2009, it is dif-
ficult to determine what is purely clinical and what is
basic science; there is significant overlap and blurring.
To clarify, one way is to define as clinical any investiga-
tions that use exclusively humans in trials. However,
using human cells in culture could be classified as an
overlap between basic science and clinical investigations.
One would not argue that animal models constitute basic
science, or that this category would include products
from animals or plants and their role in modulating dis-
ease. Taking this stance has provided me, the biologist/
immunologist, with a chance to explore those areas that
(i) overlap, (ii) are biological, (iii) are immunological,
and (iv) have a certain ‘‘orientation’’ or trajectory that
renders them intimately pertinent to complementary and
alternative medicine (CAM). Clinical evidence-based
approaches present unique problems primarily due to
human nature and are often difficult to structure, sup-
port, plan and complete. We must also examine ethical
implications and what may emerge as reputable. It is not
always easy to move past single-case reports, which is the
base of the hierarchical evidence-based pyramid suggested
by Goldrosen and Strauss (1), a paper that has been
emphasized as a model as it relates to CAM and immu-
nology and evidence-based analyses (2).
For the following analysis exemplifying the benefit of
sufficiently supported CAM approaches to clinical prob-
lems, please permit me to focus on clinical analyses
published by members of the Editorial Board. These
are not meant to be exclusive, nor do I intend to neglect
others, but with limited space I am compelled to be brief.
In fact, I hope that this discussion will inspire and stim-
ulate us, despite our busy schedules, to take a look every
month at what papers are cited. As my recollection goes,
those that are mentioned in the top-50 cited papers on
this current list of June 1, 2009 have already regularly
appeared earlier. One can easily scroll down after acces-
sing any one of the 50 to determine which journals have
cited the paper. Even more interesting, OUP provides
another service, the possibility to send e-letters that
reveal all sorts of opinions from readers. As an example
of what is of interest, readers are invited to view and to
see what has been published and that remains on the list
of 50. Of that, a total of 16 listed papers are by members
of the Editorial Board and they cover a number of sub-
jects: those that clearly constitute basic science and those
that represent clinical analyses. In the following, I have
chosen to focus on the clinical area of pain and how
authors have analyzed it, to illustrate such a wide array
of topics of highly-cited studies, both basic and clinical,
in one subject area.
According to Ma (3), it has long been accepted that
acupuncture; that is, puncturing and scraping needles at
certain points on the body, can have analgesic, anesthetic,
as well as therapeutic use in treating various diseases.
Ma underscores the international importance of this ther-
apy that involves the nervous system, neurotransmitters,
endogenous substances and Jingluo (meridians), all of
which may respond to needling stimulation and electrical
acupuncture. There is now an abundance of information
related to the neurobiological mechanisms of acupunc-
ture, with respect to both neural pathways and neuro-
transmitters/hormonal factors that mediate autonomic
regulation, pain relief and other therapeutics. From
early works we understand that the analgesic effects of
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properly cited.electroacupuncture (EA) are mediated by opioid peptides
in the periaqueductal gray, and that nitric oxide plays an
important role in mediating the cardiovascular responses
to EA stimuation through the gracile nucleus-thalamic
pathway. In addition, we know that other substances,
including serotonin, catecholamines, inorganic chemicals
and amino acids such as glutamate and a-aminobutyric
acid (GABA), mediate certain cardiovascular and analge-
sic effects, without a clear understanding of their role.
As a result, there is now increased interest in acupuncture
health care, spawning further investigations in this field.
Areas include processes of the sense of needling touch,
transduction of needling stimulation signals, stimulation
parameters and placebos. Toward higher centers, both,
evidence and understanding of neurobiological processes
of acupuncture research focus on recent developments of
nitric oxide mediating acupuncture signals through the
dorsal medulla-thalamic pathways.
Acupuncture has been analyzed from a different angle
by Lim’s group in a publication by Dong Lee et al. (4),
where both basic and clinical approaches have been
examined. Bee venom acupuncture (BVA) is often
referred to as a kind of ‘herbal’ acupuncture. After
administration, it exerts pharmacological actions from
the bioactive compounds isolated from the bee venom.
Moreover, there is the added benefit of a mechanical
function derived from acupuncture stimulation. Dong
Lee et al. declare that BVA is growing in popularity,
especially in Korea, as it is used primarily for relief
of pain in many diseases. To underscore its importance,
this group summarized and evaluated evidence of BVA
in treatment of rheumatoid arthritis and osteoarthritis.
They used various computerized literature searches
(e.g. PUBMED, EMBASE and the Cochrane Library),
focusing on basic science and clinical trials of BVA
for arthritis. Moreover, the team examined two leading
Korean journals (The Journal of Korean Society for
Acupuncture and Moxibustion and The Journal of
Korean Oriental Medicine). They found 67 studies, 15 of
which met their criteria, two of which in turn investigate
the anti-inflammation and analgesic actions of BVA.
Both actions were confirmed with several animal arthritic
models. For clinical analyses, two randomized controlled
trials and three uncontrolled clinical trials showed that
BVA was effective in treating arthritis. Although the
use of BVA in treating arthritis is a promising area
also for future research, there is already unchallenged
but limited evidence demonstrating efficacy of BVA
in arthritis. Rigorous trials that include (i) large sample
sizes, (ii) adequate design, (iii) optimal dosage and
(iv) concentration of BVA must be employed in order
to define its role, exemplifying the benefit of rigorous
basic science approaches to clinical problems.
Lewith and his group (5) analyzed acupuncture in
a manner that resembles that of Ma (3). Lewith et al.
systematically researched the literature, examining the
effect of acupuncture on brain activation as measured
by functional magnetic resonance imaging and positron
emission tomography. Results revealed that specific, and
largely predictable, areas of brain activation and deacti-
vation occurred when considering the traditional Chinese
functions attributable to certain specific acupuncture
points. As an example, points associated with hearing
and vision stimulated the visual and auditory cerebral
areas. Pain, however, is a complex matrix that is inti-
mately intertwined with expectation. Thus, the authors
found that acupuncture clearly affects this matrix in
both specific and non-specific ways that were consistent
with specific clinical effects of pain. Moreover, they
observed an effect of the expectation of the relief of pain.
Using properly supported CAM to treat pain in pedi-
atric populations has increased considerably in recent
years, according to Tsao and Zeltzer (6). Usage is espe-
cially pertinent for chronic conditions such as cancer,
rheumatoid arthritis and cystic fibrosis, where pain pres-
ents a significant problem. Tsao and Zeltzer assert that
despite the growing popularity of CAM to treat pediatric
pain, concerns about the efficacy of these interventions
remain. What then are the efficacy of CAM interventions
for pain symptoms in children? CAM modalities have
been analyzed, as revealed in recent publications includ-
ing controlled trials and/or multiple baseline studies that
focused on either chronic or acute, procedural pain.
Efficacy of CAM interventions was evaluated according
to the framework developed by the American Psycholo-
gical Association (APA) Division 12 Task Force on
Promotion and Dissemination of Psychological Proce-
dures. Results revealed that, according to these criteria,
only one CAM approach (self-hypnosis/guided imagery/
relaxation for recurrent pediatric headache) qualified as
an empirically supported therapy (EST). However, this
did not rule out the fact that many may be considered
possibly efficacious or promising treatments for pediatric
pain. Once certain methodological limitations are
resolved, there seems to be promising improvement for
future avenues of research.
In conclusion, I would like to stress the need for more
CAM approaches to clinical problems, of course recog-
nizing the pitfalls and the rewards if sufficient support
is offered. This includes adequate support and proper
examination of all parameters that surround the future
efficacy of a particular trial. One possible approach to
study design is to consider the extensive instructions
provided by OUP for designing and ultimately publishing
the outcomes of successful clinical trials. For that pur-
pose, provided herein is an excerpt from the extensively
280 Editorialreworked instructions to authors on kinds of Clinical
Papers that would be considered for publication: of
course after appropriate peer review. eCAM will give
serious consideration to peer review the following kinds
of clinical papers:
1. Brief Case Reports: The brief case reports describe, in
600 words, a single interesting case. The main criterion
for selection of a case is that it should address a signif-
icant question in the CAM community or enable readers
to learn something. Case reports can be but do not have
to be reports of rare conditions. They can report unusual
presentations of more common conditions, challenging
differential diagnoses, mistaken diagnoses, novel or
uncommon methods of treatment or unexpected out-
comes. Preferably the case should have a good illustra-
tion. Consent for publication in print and electronically
must be obtained from the patient or, if this is not pos-
sible, the next of kin. (See Patients’ consent and permis-
sion to publish).
2. Developed case reports with detailed, illustrative docu-
mentation: These detailed case reports are from 1500 to
2000 words. They may be longer, up to 5000 words, if a
series of cases is reported or if there is a demonstrable
need for a long introduction to review the literature.
These reports should be accompanied by illustrative
figures. eCAM’s preference is for brief case reports and
the longer ones will go through a strict review by the
editorial office before deemed worthy to enter the
review system.
3. Case reports expanded into hypotheses: These case
reports are from 1500 to 2000 words or up to 5000
words if describing a series of cases. The case or cases
should be strictly analyzed and a hypothesis developed.
4. Clinical studies with as strong an evidence base as
possible: Clinical studies should be submitted in the
form of Original Articles. Authors should note that the
journal place importance on evidence. It is preferred that
randomized–controled studies with double-blinded proce-
dures are performed. If the nature of the study does not
allow such study design, authors should give thorough
explanation as to why this is not possible, and how
they have handled the problem to minimize bias.
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